BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25831642)

  • 1. Radical surgical management of periampullary duodenal adenocarcinoma: a single institution experience.
    Bhatti AB; Yosuf MA; Syed AA
    J Pak Med Assoc; 2014 Nov; 64(11):1260-4. PubMed ID: 25831642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.
    Rose DM; Hochwald SN; Klimstra DS; Brennan MF
    J Am Coll Surg; 1996 Aug; 183(2):89-96. PubMed ID: 8696551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphology, TNM staging and survival with Pancreatico-duodenectomy specimens received at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan.
    Qureshi A; Hassan U; Azam M
    Asian Pac J Cancer Prev; 2011; 12(4):953-6. PubMed ID: 21790232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes in patients with duodenal adenocarcinoma.
    Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
    ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of primary duodenal adenocarcinoma.
    Hu JX; Miao XY; Zhong DW; Dai WD; Liu W; Hu W
    Hepatogastroenterology; 2006; 53(72):858-62. PubMed ID: 17153441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.
    Riall TS; Cameron JL; Lillemoe KD; Winter JM; Campbell KA; Hruban RH; Chang D; Yeo CJ
    Surgery; 2006 Nov; 140(5):764-72. PubMed ID: 17084719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of peri-ampullary tumors: a retrospective study.
    Fathy O; Abdel-Wahab M; Elghwalby N; Sultan A; El-Ebidy G; Abu-Zeid M; Abd-Allah T; El-Shobary M; Fouad A; Kandeel T; Abo-Elenien A; El-Hah NG; Abdel-Raouf A; Sultan AM; Ezzat F
    Hepatogastroenterology; 2008; 55(85):1463-9. PubMed ID: 18795713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of radical resection for locally advanced duodenal adenocarcinoma.
    Bucher P; Gervaz P; Morel P
    Hepatogastroenterology; 2005; 52(66):1727-9. PubMed ID: 16334766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreaticoduodenal resection for malignancy in a low-volume center: long-term outcomes from a developing country.
    Bhatti AB; Yusuf MA; Kazmi SA; Syed AA
    World J Surg; 2014 Oct; 38(10):2506-13. PubMed ID: 24858190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma.
    Kim MJ; Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Suh SO; Choi SY
    Kaohsiung J Med Sci; 2014 May; 30(5):254-9. PubMed ID: 24751389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.
    Jiang QL; Huang XH; Chen YT; Zhang JW; Wang CF
    Biomed Res Int; 2016; 2016():6491049. PubMed ID: 28116301
    [No Abstract]   [Full Text] [Related]  

  • 12. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
    Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
    Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical outcomes for duodenal adenoma and adenocarcinoma: a multicentre study in Australia and the United Kingdom.
    Lee CHA; Shingler G; Mowbray NG; Al-Sarireh B; Evans P; Smith M; Usatoff V; Pilgrim C
    ANZ J Surg; 2018 Mar; 88(3):E157-E161. PubMed ID: 28122405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What prognostic factors are important in duodenal adenocarcinoma?
    Bakaeen FG; Murr MM; Sarr MG; Thompson GB; Farnell MB; Nagorney DM; Farley DR; van Heerden JA; Wiersema LM; Schleck CD; Donohue JH
    Arch Surg; 2000 Jun; 135(6):635-41; discussion 641-2. PubMed ID: 10843358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients.
    Santoro E; Sacchi M; Scutari F; Carboni F; Graziano F
    Hepatogastroenterology; 1997; 44(16):1157-63. PubMed ID: 9261617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of curative and palliative treatment of duodenal adenocarcinoma].
    Bendixen M; Dahl S; Fristrup C; Mortensen MB
    Ugeskr Laeger; 2010 May; 172(18):1376-9. PubMed ID: 20444409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenterico-portal vein resection in patients with pancreatico-duodenal cancer is safe and may increase survival.
    Storkholm JH; Hansen CP
    Dan Med J; 2014 Jan; 61(1):A4757. PubMed ID: 24393587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reoperative pancreaticoduodenectomy for periampullary carcinoma.
    Shukla PJ; Qureshi SS; Shrikhande SV; Jagannath P; Desouza LJ
    ANZ J Surg; 2005 Jul; 75(7):520-3. PubMed ID: 15972035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic pancreaticoduodenectomy: technique and outcomes.
    Palanivelu C; Jani K; Senthilnathan P; Parthasarathi R; Rajapandian S; Madhankumar MV
    J Am Coll Surg; 2007 Aug; 205(2):222-30. PubMed ID: 17660068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.